Biotechnology Johnson & Johnson Advances Its Two Bladder Cancer Studies, Releases Latest Data – Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity Why Is Protara Therapeutics Stock Trading Lower On Friday? – Protara Therapeutics (NASDAQ:TARA) Read more
Biotechnology Merck’s Multi-Billion Cancer Drug Keytruda Improves Disease-Free Survival In Advanced Bladder Cancer After Surgery, Data Shows – Merck & Co (NYSE:MRK) Read more